Selected article for: "fatal case and report case"
Author: Rimmer, Kathryn; Farber, Rebecca; Thakur, Kiran; Braverman, Genna; Podolsky, Dina; Sutherland, Lauren; Migliore, Christopher; Ryu, Yun Kyoung; Levin, Seth; De Jager, Philip L; Vargas, Wendy; Levine, Libby; Riley, Claire S
Title: Fatal COVID-19 in an MS patient on natalizumab: A case report
  • Cord-id: ssms81rq
  • Document date: 2020_8_10
    • ID: ssms81rq
    Snippet: We report a fatal case of COVID-19 in a 51-year-old African American woman with multiple sclerosis on natalizumab. She had multiple risk factors for severe COVID-19 disease including race, obesity, hypertension, and elevated inflammatory markers, but the contribution of natalizumab to her poor outcome remains unknown. We consider whether altered dynamics of peripheral immune cells in the context of natalizumab treatment could worsen the cytokine storm syndrome associated with severe COVID-19. We
    Document: We report a fatal case of COVID-19 in a 51-year-old African American woman with multiple sclerosis on natalizumab. She had multiple risk factors for severe COVID-19 disease including race, obesity, hypertension, and elevated inflammatory markers, but the contribution of natalizumab to her poor outcome remains unknown. We consider whether altered dynamics of peripheral immune cells in the context of natalizumab treatment could worsen the cytokine storm syndrome associated with severe COVID-19. We discuss extended interval dosing as a risk-reduction strategy for multiple sclerosis patients on natalizumab, and the use of interleukin-6 inhibitors in such patients who contract COVID-19.

    Search related documents:
    Co phrase search for related documents
    • acute ards respiratory distress syndrome and lung volume: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32
    • acute ards respiratory distress syndrome and lymphocyte percentage: 1, 2, 3, 4, 5, 6
    • acute ards respiratory distress syndrome and magnetic resonance: 1, 2, 3, 4, 5, 6
    • lung infiltration and lymphocyte percentage: 1
    • lung infiltration and lymphopenia lung infiltration: 1, 2
    • lung infiltration and magnetic resonance: 1, 2
    • lung volume and magnetic resonance: 1, 2